netFormulary NHS
Herefordshire & Worcestershire
Medicines and Prescribing Committee
 Search
 Formulary Chapter 5: Infections - Full Chapter
Notes:

Secondary care : Please note that though there may be drugs listed with a Formulary status in this section, you should refer to the Acute Trust's antibiotic policy found here as there are some restrictions, which require microbiology approval before they can be supplied by Pharmacy.

Primary Care - refer to local guidance for more advice

Chapter Links...
 Details...
05.03.04  Expand sub section  Influenza
Oseltamivir (Tamiflu)
View adult BNF View SPC online View childrens BNF
Formulary
Green

In line with NICE TA158 (Replaces TA67) and TA168 (Replaces TA58)

 
Link  NICE TA158 Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
Link  NICE TA168 Amantadine, oseltamivir and zanamivir for the treatment of influenza
 
Zanamivir (Relenza)
View adult BNF View SPC online View childrens BNF
Formulary
Green

In Line With NICE TA158 (Replaces TA67) and TA168 (Replaces TA15 and TA58)

 
Link  NICE TA158 Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
Link  NICE TA168 Amantadine, oseltamivir and zanamivir for the treatment of influenza
 
Zanamivir aqueous solution 10mg/mL (GSK)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Treatment is recommended within Public Health England (PHE) guidance on the use of antiviral agents for the treatment and prophylaxis of seasonal influenza.

For the treatment of critically ill adults and children having a life-threatening condition due to suspected or confirmed pandemic A(H1N1)v infection or infection due to seasonal influenza A or B virus and answering to the following criteria:

·  Patients not responding to either oral or inhaled authorised antiviral medicinal products or

·  Patients for whom drug delivery by a route other than IV (e.g. oral oseltamivir or inhaled zanamivir) is not expected to be dependable or is not feasible, or

·  Patients infected with documented oseltamivir-resistant influenza virus and not suitable for therapy with inhaled zanamivir.

 
 
 ....
 Non Formulary Items
Amantadine Hydrochloride

View adult BNF View SPC online View childrens BNF
Non Formulary
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Secondary care only, not to be prescribed in primary care.   

Amber 2

Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber with Shared Care

Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber

Considered suitable for primary care prescribing following specialist initiation/recommendation.  

Green

Considered appropriate for prescribing in both secondary and primary care. Suitable for initiation in primary care.   

netFormulary